: Compared to historical reports, both aGVHD and cGVHD appeared to have decreased in the recent transplant era, possibly due to the extension of T-cell depletion, the availability of effective second-line approaches in SR/D GVHD and improved anti-infectious prophylaxis and treatments.

Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study

Benedetti, Edoardo;Brunello, Lucia;Chiappella, Annalisa;Corradini, Paolo;Fagioli, Franca;Giaccone, Luisa;Grillo, Giovanni;Leotta, Salvatore;Musso, Maurizio;Russo, Domenico;Sica, Simona;Zallio, Francesco;
2025-01-01

Abstract

: Compared to historical reports, both aGVHD and cGVHD appeared to have decreased in the recent transplant era, possibly due to the extension of T-cell depletion, the availability of effective second-line approaches in SR/D GVHD and improved anti-infectious prophylaxis and treatments.
2025
1
6
ATG; GVHD; PTCy; axatilimab; belumosudil; hematopoietic stem cell transplantation; ruxolitinib
Polverelli, Nicola; Zerbi, Caterina; Benevento, Maria Grazia; Algeri, Mattia; Algarotti, Alessandra; Angelucci, Emanuele; Balduzzi, Adriana Cristina; ...espandi
File in questo prodotto:
File Dimensione Formato  
Paper_GITMO GHVD24_15.7.25.docx

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 215.5 kB
Formato Microsoft Word XML
215.5 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/2112151
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact